Pfizer Inc. Canadian Depositary Receipt (PFE)
TSX
Closed
Aug 25, 2026
Day's Range
12.4052 wk Range
10.57Overview - PFE - Pfizer Inc. Canadian Depositary Receipt
Key Statistics
Valuation
Enterprise Value
284.03B
P/E (Trailing)
‪35.33‬
PEG Ratio
‪-0.32‬
Price / Sales (TTM)
‪3.53‬
Price / Book
‪2.49‬
EV / EBITDA
‪11.03‬
Profitability
Gross Margin
‪72.78%‬
Profit Margin
‪74.32%‬
Operating Margin
‪16.28%‬
Return on Assets
‪3.73%‬
Return on Equity
‪8.95%‬
Ownership
Shares Outstanding
5.69B
Price stats
50-Day Avg
‪11.36‬
200-Day Avg
‪11.75‬
Dividends
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - PFE - Pfizer Inc. Canadian Depositary Receipt
Peers - PFE - Pfizer Inc. Canadian Depositary Receipt
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on TSX.
Profile Summary - PFE - Pfizer Inc. Canadian Depositary Receipt
About
Pfizer Inc. Canadian Depositary Receipt is an equity security that provides Canadian investors with fractional economic exposure to Pfizer Inc., one of the world’s largest research‑based pharmaceutical companies. The receipt represents an interest in Pfizer shares while trading in Canadian dollars, with a built‑in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
